Hectorol and Emla drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Hectorol (doxercalciferol) and Emla (lidocaine; prilocaine). Common drug interactions include abdominal pain among females and activated partial thromboplastin time prolonged among males.

The phase IV clinical study analyzes what interactions people have when they take Hectorol and Emla. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Hectorol?

Hectorol has active ingredients of doxercalciferol. eHealthMe is studying from 1,815 Hectorol users. Check the latest studies of Hectorol.

What is Emla?

Emla has active ingredients of lidocaine; prilocaine. eHealthMe is studying from 5,276 Emla users. Check the latest studies of Emla.

On Jul, 24, 2026

12 people who take Hectorol and Emla together, and have interactions are studied.

What are the common drug interactions of Hectorol and Emla, by gender? *:

female:

Abdominal pain
Headache (pain in head)
Nausea (feeling of having an urge to vomit)
Sepsis (a severe blood infection that can lead to organ failure and death)
Chills (felling of cold)
Pyrexia (fever)
Vomiting
Abdominal distension
Arrhythmia (irregular heartbeat)
Cardiac arrest

male:

Activated partial thromboplastin time prolonged
Arteriovenous fistula thrombosis (formation of a blood clot inside a blood vessel-av fistula)
Vomiting
White blood cell count decreased
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Diarrhoea
Drug specific antibody present
Hypoparathyroidism (inadequate secretion of parathyroid hormone resulting in abnormally low levels of calcium in the blood)
Nausea (feeling of having an urge to vomit)
Platelet count decreased

What are the common drug interactions of Hectorol and Emla, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Activated partial thromboplastin time prolonged
Arteriovenous fistula thrombosis (formation of a blood clot inside a blood vessel-av fistula)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Diarrhoea
Drug specific antibody present
Hypoparathyroidism (inadequate secretion of parathyroid hormone resulting in abnormally low levels of calcium in the blood)
Nausea (feeling of having an urge to vomit)
Platelet count decreased
Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue)
Therapeutic response decreased (less preventive response)

40-49:

Headache (pain in head)

50-59:

Chronic kidney disease
Diabetic nephropathy (diabetic kidney disease)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Nephrogenic anaemia (anaemia due to kidney disease)
Renal failure (kidney dysfunction)

60+:

Abdominal pain
Nausea (feeling of having an urge to vomit)
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Dyspnoea (difficult or laboured respiration)
Hypertension (high blood pressure)
Peritonitis bacterial (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs by bacterial)
Renal failure chronic (long lasting kidney dysfunction)
Decreased appetite
Fluid overload (too much fluid in the blood)
Hypotension (abnormally low blood pressure)

What are the existing conditions these people have? *

Hyperparathyroidism Secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary): 3 people, 25.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 16.67%
Oedema (fluid collection in tissue): 1 person, 8.33%
Itching: 1 person, 8.33%
Hyperparathyroidism (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium): 1 person, 8.33%
High Blood Cholesterol: 1 person, 8.33%
Gout (uric acid crystals building up in the body): 1 person, 8.33%
Chronic Renal Failure (kidney failure): 1 person, 8.33%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Hectorol and Emla?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously